The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe
Abstract
BACKGROUND: Data on more than a decade of outpatient quinolone use were collected from 33 European countries within the European Surveillance of Antimicrobial Consumption (ESAC) project, funded by the European Centre for Disease Prevention and Control (ECDC). METHODS: For the period 1997-2009, data on outpatient use of systemic quinolones aggregated at the level of the active substance were collected using the Anatomical Therapeutic Chemical (ATC)/defined daily dose (DDD) method (WHO, version 2011), and expressed in DDD and packages per 1000 inhabitants per day (DID and PID, respectively). Using a classification based on pharmacokinetic and in vitro potency profiles, quinolone use was analysed with regard to trends over time, seasonal variation and composition. RESULTS: Total outpatient quinolone use in 2009 varied by a factor of 7.5 between the country with the highest (Italy, 3.61 DID) and the country with the lowest (the UK, 0.48 DID) quinolone use. The second-generation quinolones accounted for >50% of quinolone use (mainly ciprofloxacin), except for Croatia, where first-generation quinolones (mainly norfloxacin) were mostly used. A significant increase in outpatient quinolone use was found for Europe, as well as a large seasonal variation, which increased significantly over time from 1997 to 2009. Relative use of third-generation quinolones significantly increased over time with respect to the use of second-generation quinolones, while the relative use of both significantly increased with respect to the first-generation quinolones. Levofloxacin and moxifloxacin (respiratory quinolones) represented >10% of quinolone outpatient use in 17 countries, with extreme seasonal variation in all countries. CONCLUSIONS: There was a substantial increase and change in the pattern of quinolone use between 1997 and 2009, a period during which quinolones that are effective for the treatment of respiratory tract infections were introduced. These quinolones are not the first-line antibiotics for this indication and their use should generally be limited, and quinolones should ideally show no substantial seasonal variation in terms of their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Self-citationGuidelines for the management of adult lower respiratory tract infections
Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., & Verheij, T. J. M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00055705 · Cited by 895
WHO Regional Office for Europe
Tsechkovski, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91122-3 · Cited by 871
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Antimicrobial Drug Use and Resistance in Europe
van de Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E., Monen, J., Goossens, H., Ferech, M., & the European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Project Groups (2008) · Emerging Infectious Diseases · doi:10.3201/eid1411.070467 · Cited by 485
Self-citationGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Adriaenssens, N., Coenen, S., Tonkin-Crine, S., Verheij, T. J. M., Little, P., & Goossens, H. (2011) · BMJ Quality & Safety · doi:10.1136/bmjqs.2010.049049 · Cited by 309
Self-citationQuinolone generations: natural history or natural selection?
Ball, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 302
Coenen, S., Ferech, M., Haaijer-Ruskamp, F. M., Butler, C. C., Vander Stichele, R. H., Verheij, T. J. M., Monnet, D. L., Little, P., Goossens, H., & the ESAC Project Group (2007) · Quality and Safety in Health Care · doi:10.1136/qshc.2006.021121 · Cited by 245
Self-citationGrigoryan, L., Burgerhof, J. G. M., Degener, J. E., Deschepper, R., Lundborg, C. S., Monnet, D. L., Scicluna, E. A., Birkin, J., Haaijer-Ruskamp, F. M., & on behalf of the Self-Medication with Antibiotics and Resistance (SAR) Consortium (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn054 · Cited by 224
National campaigns to improve antibiotic use
Goossens, H., Guillemot, D., Ferech, M., Schlemmer, B., Costers, M., van Breda, M., Baker, L. J., Cars, O., & Davey, P. G. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0094-7 · Cited by 211
Self-citationIs self-medication with antibiotics in Europe driven by prescribed use?
Grigoryan, L., Burgerhof, J. G. M., Haaijer-Ruskamp, F. M., Degener, J. E., Deschepper, R., Monnet, D. L., Matteo, A. D., Scicluna, E. A., Bara, A.-C., Lundborg, C. S., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl457 · Cited by 171
Versporten, A., Coenen, S., Adriaenssens, N., Muller, A., Minalu, G., Faes, C., Vankerckhoven, V., Aerts, M., Hens, N., Molenberghs, G., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr454 · Cited by 145
Self-citationStichele, R. V., Elseviers, M. M., Ferech, M., Blot, S. I., Goossens, H., & the ESAC Project Group (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02164.x · Cited by 127
Self-citationWood, F., Simpson, S. A., & Butler, C. (2007) · Family Practice · doi:10.1093/fampra/cmm040 · Cited by 118
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe
Ferech, M., Coenen, S., Malhotra‐Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C., & Goossens, H. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl183 · Cited by 111
Self-citationNathwani, D., Sneddon, J., Malcolm, W., Wiuff, C., Patton, A., Hurding, S., Eastaway, A., Seaton, R. A., Watson, E., Gillies, E., et al. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.005 · Cited by 97
Adverse drug reactions: implications for the development of fluoroquinolones
Ball, P. D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg209 · Cited by 90
Coenen, S., Ferech, M., Malhotra‐Kumar, S., Hendrickx, E., Suetens, C., & Goossens, H. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl184 · Cited by 90
Self-citationSchep‐Akkerman, A., van der Wouden, J. C., Kuyvenhoven, M. M., Dieleman, J. P., & Verheij, T. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh480 · Cited by 87
Association Between Antibiotic Sales and Public Campaigns for Their Appropriate Use
Bauraind, I., López-Lozano, J.-M., Beyaert, A., Marchal, J.-L., Seys, B., Yane, F., Hendrickx, E., Goossens, H., Tulkens, P. M., & VERBIST, L. (2004) · JAMA · doi:10.1001/jama.292.20.2468-b · Cited by 61
Self-citationDavey, P. G., Ferech, M., Ansari, F., Müller, A., & Goossens, H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn386 · Cited by 55
Self-citationThe More Antibacterial Trade Names, The More Consumption of Antibacterials: A European Study
Monnet, D. L., Ferech, M., Møller, J. K., & Goossens, H. (2005) · Clinical Infectious Diseases · doi:10.1086/430822 · Cited by 46
Self-citationProblems in collecting comparable national drug use data in Europe: the example of antibacterials
Rønning, M., Blix, H. S., Strøm, H., Skovlund, E., Andersen, M. T., & Stichele, R. V. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0572-8 · Cited by 41
Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis
Faes, C., Molenberghs, G., Hens, N., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr461 · Cited by 33
Minalu, G., Aerts, M., Coenen, S., Versporten, A., Müller, A., Adriaenssens, N., Beutels, P., Molenberghs, G., Goossens, H., & Hens, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr460 · Cited by 27
Self-citationCoenen, S., & Mölstad, S. (2004) · European Journal of General Practice · doi:10.3109/13814780409044306 · Cited by 12
Self-citationSecular trends in antibiotic consumption in the adult population in Emilia-Romagna, Italy, 2003–2009
Pan, A., Buttazzi, R., Marchi, M., Gagliotti, C., Resi, D., & Moro, M. L. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03500.x · Cited by 12
Management of acute cough: Comparisons between Belgian and Dutch GPs
Coenen, S., Welschen, I., Royen, P. V., Kuyvenhoven, M. M., Denekens, J., & Verheij, T. J. (2004) · European Journal of General Practice · doi:10.3109/13814780409044303 · Cited by 6
Self-citation
Cited by
Zhang, Q.-Q., Ying, G.-G., Pan, C.-G., Liu, Y.-S., & Zhao, J.-L. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b00729 · Cited by 3,852
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Costelloe, C., Metcalfe, C., Lovering, A., Mant, D., & Hay, A. D. (2010) · BMJ · doi:10.1136/bmj.c2096 · Cited by 1,981
Environmental pollution by antibiotics and by antibiotic resistance determinants
Martinez, J. L. (2009) · Environmental Pollution · doi:10.1016/j.envpol.2009.05.051 · Cited by 1,912
Degradation and removal methods of antibiotics from aqueous matrices – A review
Homem, V., & Santos, L. (2011) · Journal of Environmental Management · doi:10.1016/j.jenvman.2011.05.023 · Cited by 1,521
Metadata
- Authors
- Ferech, M., Coenen, S., Malhotra-Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C., & Goossens, H.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-30
- Volume
- 58
- Issue
- 2
- Pages
- 401-407
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2130752053
- Cited by
- 598
- References
- 30
- FWCI
- 25.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.